Prosecution Insights
Last updated: April 19, 2026

Sumitomo Pharma Co., Ltd.

11 pending office actions

Portfolio Summary

11
Total Pending OAs
4
Final Rejections
7
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
19095723 MEDICAMENT FOR TREATING CANCER COMPRISING OPTICALLY ACTIVE AZABICYCLO RING DERIVATIVE ABDALHAMEED, MANAHIL MIRGHANI ALI 1622 Final Rejection Mar 31, 2025
18723166 1H-PYRAZOLE-3-AMINE DERIVATIVE HAVING BICYCLIC BACKBONE SONG, JIANFENG 1613 Non-Final OA Jun 21, 2024
18545081 DISPLAY CONTROL APPARATUS, AND DISPLAY CONTROL METHOD ZHU, QIN 2691 Non-Final OA Dec 19, 2023
18258989 THERAPY BASED ON SYNTHETIC LETHALITY IN SWI/SNF COMPLEX-DYSFUNCTION CANCER ROMERO, KRISTEN WANG 1624 Non-Final OA Jun 22, 2023
18025036 Complex Containing Neural Retina-Containing Cell Aggregates and Matrix, and Method for Manufacturing Same CORDAS, EMILY ANN 1632 Non-Final OA Mar 07, 2023
18113887 THERAPEUTIC DRUG FOR MOTOR COMPLICATIONS IN PARKINSON'S DISEASE NOTTINGHAM, KYLE GREGORY 1621 Non-Final OA Feb 24, 2023
17794912 DETERMINATION AGENT AND DETERMINATION METHOD FOR TAUOPATHY AND DEMENTIA-RELATED DISEASES WANG, CHANG YU 1675 Non-Final OA Jul 22, 2022
17600903 WATER SOLUBLE ADJUVANT AND COMPOSITION CONTAINING SAME VAN DRUFF, SYDNEY 1643 Final Rejection Oct 01, 2021
17417871 PREPARATION INCLUDING VACCINE ADJUVANT KIM, YUNSOO 1641 Final Rejection Jun 24, 2021
17279807 INJECTABLE COMPOSITION STEELE, AMBER D 1658 Non-Final OA Mar 25, 2021
13895089 NOVEL BICYCLIC HETEROCYCLIC COMPOUND STOCKTON, LAURA LYNNE 1626 Final Rejection May 15, 2013

Managing Sumitomo Pharma Co., Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month